Since it was shown that administration of GLP-1 receptor agonist in subjects with type 2 diabetes resulted in reduction of cardiovascular-related events and/or death17, the role of GLP-1 receptor in vascular cells has been drawing much more attention in clinicians as well as researchers. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.